» Articles » PMID: 35307400

The Importance of Neopterin in COVID-19: The Prognostic Value and Relation with the Disease Severity

Overview
Journal Clin Biochem
Specialty Biochemistry
Date 2022 Mar 21
PMID 35307400
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus Disease 2019 [COVID-19], caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], has rapidly evolved into a global health emergency. Neopterin [NPT], produced by macrophages when stimulated with interferon [IFN-]gamma, is an essential cytokine in the antiviral immune response. NPT has been used as a marker for the early assessment of disease severity in different diseases. The leading cause of NPT production is the pro-inflammatory cytokine IFN-. Macrophage activation has also been revealed to be linked with disease severity in SARS-CoV-2 patients. We demonstrate the importance of NPT in the pathogenesis of SARS-CoV-2 and suggest that targeting NPT in SARS-CoV-2 infection may be critical in the early prediction of disease progression and provision of timely management of infected individuals.

Citing Articles

GDF15, EGF, and Neopterin in Assessing Progression of Pediatric Chronic Kidney Disease Using Artificial Intelligence Tools-A Pilot Study.

Musial K, Stojanowski J, Bargenda-Lange A, Golebiowski T Int J Mol Sci. 2025; 26(5).

PMID: 40076962 PMC: 11899747. DOI: 10.3390/ijms26052344.


Evaluation of serum neopterin levels in severe COVID-19 patients: An observational study.

Gurcu S, Kaya Z, Uncu A, Yorulmaz G, Ilgin S Medicine (Baltimore). 2024; 103(30):e38996.

PMID: 39058886 PMC: 11272344. DOI: 10.1097/MD.0000000000038996.


The usability of neopterin in determining disease course in COVID-19.

Ozatag D, Korkmaz P, Keskin H, Kocak H Saudi Med J. 2023; 44(8):767-772.

PMID: 37582565 PMC: 10425625. DOI: 10.15537/smj.2023.44.8.20230365.


Neopterin, the Cell-Mediated Immune Response Biomarker, in Inflammatory Periodontal Diseases: A Narrative Review of a More than Fifty Years Old Biomarker.

Heneberk O, Wurfelova E, Radochova V Biomedicines. 2023; 11(5).

PMID: 37238968 PMC: 10215987. DOI: 10.3390/biomedicines11051294.


Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children.

Sinkovits G, Schnur J, Hurler L, Kiszel P, Prohaszka Z, Sik P Sci Rep. 2022; 12(1):19759.

PMID: 36396679 PMC: 9670087. DOI: 10.1038/s41598-022-23806-5.

References
1.
Al-Samkari H, Berliner N . Hemophagocytic Lymphohistiocytosis. Annu Rev Pathol. 2017; 13:27-49. DOI: 10.1146/annurev-pathol-020117-043625. View

2.
Daniels L, Ren J, Kumar K, Bui Q, Zhang J, Zhang X . Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry. PLoS One. 2021; 16(7):e0254635. PMC: 8281996. DOI: 10.1371/journal.pone.0254635. View

3.
Lau J, Horvath C . Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responses. Mt Sinai J Med. 2002; 69(3):156-68. View

4.
Muller M, Curtius H, Herold M, Huber C . Neopterin in clinical practice. Clin Chim Acta. 1991; 201(1-2):1-16. DOI: 10.1016/0009-8981(91)90019-9. View

5.
Matsushita H, Hosoi A, Ueha S, Abe J, Fujieda N, Tomura M . Cytotoxic T lymphocytes block tumor growth both by lytic activity and IFNγ-dependent cell-cycle arrest. Cancer Immunol Res. 2014; 3(1):26-36. DOI: 10.1158/2326-6066.CIR-14-0098. View